Janusz Hałka - Klinika Chorób Wewnętrznych i Hematologii, Wojskowy Instytut Medyczny

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 38 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

A Hybrid Protocol CLAG-M, a Possible Player for the First-Line Therapy of Patients with Mixed Phenotype Acute Leukemia. A Polish Adult Leukemia Group Experience

Magdalena Karasek,Anna Armatys,Marek Skarupski,Lukasz Bolkun,Katarzyna Budziszewska,Joanna Drozd-Sokolowska,Ewa Zarzycka,Patrycja Mensah-Glanowska,Malgorzata Gajewska,Janusz Halka,Agnieszka Kopacz, Witold Prejzer, Olga Chyrko,Tomasz Wrobel,Agnieszka Wierzbowska,Marta Sobas

Frontiers in Oncology (2024)

Cited0Views0WOSBibtex

A Polish Adult Leukemia Group (PALG) Prospective International Randomized Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 Vs DAC) in Acute Myeloid Leukemia (AML) Patients ≤ 60 Years Old (PALG-AML1/2016) - Topline Results

Bloodno. Supplement 1 (2024): 970-970

Cited0Views0Bibtex

Standard Non-Intensive Chemotherapy Vs Venetoclax-Azacytidine (Ven-Aza) for Unfit AML Patients with Therapy-Related Acute Myeloid Leukaemia (T-Aml) - a Retrospective Study of Polish Adult Leukemia Group (PALG)

Lukasz Bolkun,Judyta Strzala,Magdalena Czemerska,Bozena Katarzyna Budziszewska,Aleksandra Golos, Anna Holownia,Wanda Knopinska-Posluszny,Ewa Lech Maranda,Jaroslaw Piszcz,Janusz Halka,Agnieszka Wierzbowska

BLOOD (2024): 6056-6057

Cited0Views0Bibtex

P491: DAY 14 MEASURABLE RESIDUAL DISEASE ASSESSMENT PREDICTS TREATMENT OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY - RESULTS OF THE PALG-AML1/2016 STUDY

HemaSphereno. S3 (2023)

Cited0Views0Bibtex

The Use of Interventional Radiology in the Diagnosis and Treatment of Gastric Bleeding in Burkitt Lymphoma

Grzegorz Kade, Adam Kade, Agata Kurowska,Rafał Kidziński,Krzysztof Pyra,Sebastian Spaleniak,Janusz Hałka

OncoReviewno. 3(51) (2023): 85-89

Cited0Views0Bibtex

Zilovertamab Vedotin Alone or in Combination with Nemtabrutinib in Aggressive and Indolent B-Cell Malignancies: Phase 2Waveline-006Study

Pier Luigi Zinzani,Jiri Mayer,Ohad Benjamini,Alejandro Berkovits,Ingrid Glimelius,Don Stevens,Arvind Chaudhry,Ahmet Muzaffer Demir,Ramon Garcia Sanz,Won Seog Kim,Li Fei,Janusz Halka,Ana Marin-Niebla,Muhit Ozcan,Ewa Paszkiewicz-Kozik,Armando Santoro,Ren Yixin,Uzor Ogbu,Patricia Marinello, Wojcieich Jurczak

AMERICAN JOURNAL OF HEMATOLOGY (2023): S51-S52

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn